Published 17 May 2004. doi:10.1084/jem.20040191
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 199, Number 10, 1421-1431
Endogenous Presentation of CD8+ T Cell Epitopes from Epstein-Barr Virusencoded Nuclear Antigen 1
Judy Tellama,b,
Geoff Connollya,b,
Katherine J. Greena,b,
John J. Milesa,b,
Denis J. Mossa,b,
Scott R. Burrowsa,b, and
Rajiv Khannaa,b
a Tumour Immunology Laboratory, Division of Infectious Diseases and Immunology, Clive Berghofer Cancer Research Centre, Queensland Institute of Medical Research, Brisbane (Qld) 4006, Australia
b Department of Molecular and Cellular Pathology, University of Queensland, Brisbane (Qld) 4006, Australia
Address correspondence to Rajiv Khanna, EBV Unit, Tumour Immunology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, 300 Herston Road, Brisbane (Qld) 4006, Australia. Phone: 61-7-33620385; Fax: 61-7-38453510; email: rajivK{at}qimr.edu.au; or Scott R. Burrows, EBV Unit, Tumour Immunology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, 300 Herston Road, Brisbane (Qld) 4006, Australia. Phone: 61-7-38453793; Fax: 61-7-38453510; email: scottB{at}qimr.edu.au
Epstein-Barr virus (EBV)encoded nuclear antigen (EBNA)1 is thought to escape cytotoxic T lymphocyte (CTL) recognition through either self-inhibition of synthesis or by blockade of proteasomal degradation by the glycine-alanine repeat (GAr) domain. Here we show that EBNA1 has a remarkably varied cell typedependent stability. However, these different degradation rates do not correspond to the level of major histocompatibility complex class Irestricted presentation of EBNA1 epitopes. In spite of the highly stable expression of EBNA1 in B cells, CTL epitopes derived from this protein are efficiently processed and presented to CD8+ T cells. Furthermore, we show that EBV-infected B cells can readily activate EBNA1-specific memory T cell responses from healthy virus carriers. Functional assays revealed that processing of these EBNA1 epitopes is proteasome and transporter associated with antigen processing dependent. We also show that the endogenous presentation of these epitopes is dependent on the newly synthesized protein rather than the long-lived stable EBNA1. Based on these observations, we propose that defective ribosomal products, not the full-length antigen, are the primary source of endogenously processed CD8+ T cell epitopes from EBNA1.
Key Words: EBNA1 CD8+ T cell antigen processing DRiPs proteasome
S.R. Burrows and R. Khanna contributed equally to this work.
Abbreviations used in this paper: BFA, brefeldin A; DRiPs, defective ribosomal products; EBNA, EBV-encoded nuclear antigen; GAr, glycine-alanine repeat; GFP, green fluorescent protein; HA, hemagglutinin; LCL, lymphoblastoid cell line; LMP1, latent membrane protein 1; TAP, transporter associated with antigen processing; Ub, ubiquitin.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Gurer, C., Strowig, T., Brilot, F., Pack, M., Trumpfheller, C., Arrey, F., Park, C. G., Steinman, R. M., Munz, C.
(2008). Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood
112: 1231-1239
[Abstract]
[Full Text]
-
Lunemann, J. D., Frey, O., Eidner, T., Baier, M., Roberts, S., Sashihara, J., Volkmer, R., Cohen, J. I., Hein, G., Kamradt, T., Munz, C.
(2008). Increased Frequency of EBV-Specific Effector Memory CD8+ T Cells Correlates with Higher Viral Load in Rheumatoid Arthritis. J. Immunol.
181: 991-1000
[Abstract]
[Full Text]
-
Tellam, J., Smith, C., Rist, M., Webb, N., Cooper, L., Vuocolo, T., Connolly, G., Tscharke, D. C., Devoy, M. P., Khanna, R.
(2008). From the Cover: Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition. Proc. Natl. Acad. Sci. USA
105: 9319-9324
[Abstract]
[Full Text]
-
Yoshioka, M., Crum, M. M., Sample, J. T.
(2008). Autorepression of Epstein-Barr Virus Nuclear Antigen 1 Expression by Inhibition of Pre-mRNA Processing. J. Virol.
82: 1679-1687
[Abstract]
[Full Text]
-
Goldwich, A., Hahn, S. S. C., Schreiber, S., Meier, S., Kampgen, E., Wagner, R., Lutz, M. B., Schubert, U.
(2008). Targeting HIV-1 Gag into the Defective Ribosomal Product Pathway Enhances MHC Class I Antigen Presentation and CD8+ T Cell Activation. J. Immunol.
180: 372-382
[Abstract]
[Full Text]
-
Tellam, J., Fogg, M. H., Rist, M., Connolly, G., Tscharke, D., Webb, N., Heslop, L., Wang, F., Khanna, R.
(2007). Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes. J. Exp. Med.
204: 525-532
[Abstract]
[Full Text]
-
Ito, Y., Demachi-Okamura, A., Ohta, R., Akatsuka, Y., Nishida, K., Tsujimura, K., Morishima, Y., Takahashi, T., Kuzushima, K.
(2007). Full-length EBNA1 mRNA-transduced dendritic cells stimulate cytotoxic T lymphocytes recognizing a novel HLA-Cw*0303- and -Cw*0304-restricted epitope on EBNA1-expressing cells. J. Gen. Virol.
88: 770-780
[Abstract]
[Full Text]
-
Heller, K. N., Upshaw, J., Seyoum, B., Zebroski, H., Munz, C.
(2007). Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers. Blood
109: 1138-1146
[Abstract]
[Full Text]
-
Miles, J. J., Borg, N. A., Brennan, R. M., Tynan, F. E., Kjer-Nielsen, L., Silins, S. L., Bell, M. J., Burrows, J. M., McCluskey, J., Rossjohn, J., Burrows, S. R.
(2006). TCR{alpha} Genes Direct MHC Restriction in the Potent Human T Cell Response to a Class I-Bound Viral Epitope. J. Immunol.
177: 6804-6814
[Abstract]
[Full Text]
-
Smith, C., Cooper, L., Burgess, M., Rist, M., Webb, N., Lambley, E., Tellam, J., Marlton, P., Seymour, J. F., Gandhi, M., Khanna, R.
(2006). Functional Reversion of Antigen-Specific CD8+ T Cells from Patients with Hodgkin Lymphoma following In Vitro Stimulation with Recombinant Polyepitope. J. Immunol.
177: 4897-4906
[Abstract]
[Full Text]
-
Lunemann, J. D., Edwards, N., Muraro, P. A., Hayashi, S., Cohen, J. I., Munz, C., Martin, R.
(2006). Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain
129: 1493-1506
[Abstract]
[Full Text]
-
Ito, Y., Kondo, E., Demachi-Okamura, A., Akatsuka, Y., Tsujimura, K., Tanimoto, M., Morishima, Y., Takahashi, T., Kuzushima, K.
(2006). Three Immunoproteasome-Associated Subunits Cooperatively Generate a Cytotoxic T-Lymphocyte Epitope of Epstein-Barr Virus LMP2A by Overcoming Specific Structures Resistant to Epitope Liberation. J. Virol.
80: 883-890
[Abstract]
[Full Text]
-
Fogg, M. H., Kaur, A., Cho, Y.-G., Wang, F.
(2005). The CD8+ T-Cell Response to an Epstein-Barr Virus-Related Gammaherpesvirus Infecting Rhesus Macaques Provides Evidence for Immune Evasion by the EBNA-1 Homologue. J. Virol.
79: 12681-12691
[Abstract]
[Full Text]
-
Straathof, K. C., Leen, A. M., Buza, E. L., Taylor, G., Huls, M. H., Heslop, H. E., Rooney, C. M., Bollard, C. M.
(2005). Characterization of Latent Membrane Protein 2 Specificity in CTL Lines from Patients with EBV-Positive Nasopharyngeal Carcinoma and Lymphoma. J. Immunol.
175: 4137-4147
[Abstract]
[Full Text]
-
Piriou, E., Jansen, C. A., Dort, K. v., De Cuyper, I., Nanlohy, N. M., Lange, J. M. A., van Oers, M. H. J., Miedema, F., van Baarle, D.
(2005). Reconstitution of EBV Latent but Not Lytic Antigen-Specific CD4+ and CD8+ T Cells after HIV Treatment with Highly Active Antiretroviral Therapy. J. Immunol.
175: 2010-2017
[Abstract]
[Full Text]
-
Coleman, H. M., Efstathiou, S., Stevenson, P. G.
(2005). Transcription of the murine gammaherpesvirus 68 ORF73 from promoters in the viral terminal repeats. J. Gen. Virol.
86: 561-574
[Abstract]
[Full Text]
-
Straathof, K. C. M., Bollard, C. M., Popat, U., Huls, M. H., Lopez, T., Morriss, M. C., Gresik, M. V., Gee, A. P., Russell, H. V., Brenner, M. K., Rooney, C. M., Heslop, H. E.
(2005). Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes. Blood
105: 1898-1904
[Abstract]
[Full Text]
-
Voo, K. S., Peng, G., Guo, Z., Fu, T., Li, Y., Frappier, L., Wang, R.-F.
(2005). Functional Characterization of EBV-Encoded Nuclear Antigen 1-Specific CD4+ Helper and Regulatory T Cells Elicited by In vitro Peptide Stimulation. Cancer Res.
65: 1577-1586
[Abstract]
[Full Text]
-
Paludan, C., Schmid, D., Landthaler, M., Vockerodt, M., Kube, D., Tuschl, T., Munz, C.
(2005). Endogenous MHC Class II Processing of a Viral Nuclear Antigen After Autophagy. Science
307: 593-596
[Abstract]
[Full Text]
-
Ressing, M. E., van Leeuwen, D., Verreck, F. A. W., Keating, S., Gomez, R., Franken, K. L. M. C., Ottenhoff, T. H. M., Spriggs, M., Schumacher, T. N., Hutt-Fletcher, L. M., Rowe, M., Wiertz, E. J. H. J.
(2005). Epstein-Barr Virus gp42 Is Posttranslationally Modified To Produce Soluble gp42 That Mediates HLA Class II Immune Evasion. J. Virol.
79: 841-852
[Abstract]
[Full Text]
-
Lee, S. P., Brooks, J. M., Al-Jarrah, H., Thomas, W. A., Haigh, T. A., Taylor, G. S., Humme, S., Schepers, A., Hammerschmidt, W., Yates, J. L., Rickinson, A. B., Blake, N. W.
(2004). CD8 T Cell Recognition of Endogenously Expressed Epstein-Barr Virus Nuclear Antigen 1. J. Exp. Med.
199: 1409-1420
[Abstract]
[Full Text]